DUALASE
LIVE

Serial Number

90095313

Owner

Specific Biologics Inc.

Attorney

Aaron D. Hendelman

First Use Date

Mar 20, 2018

Filing Date

Aug 5, 2020

Add to watchlist:

No watchlists yet
View on USPTO

DUALASE Trademark

Serial Number: 90095313 • Registration: 7043514

DUALASE is a trademark filed by Specific Biologics Inc. on August 5, 2020. The trademark is classified under Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Specific Biologics Inc. (8 trademarks)

Suite 1300, Bench 13103N
Toronto, Ontario M5G0B7 , CA

Entity Type: 03

Trademark Details

Filing Date

August 5, 2020

Registration Date

May 2, 2023

First Use Anywhere

March 20, 2018

First Use in Commerce

March 20, 2018

Published for Opposition

October 12, 2021

Goods & Services

Pharmaceutical products development; Pharmaceutical research and development, namely, research in the field of gene editing; Pharmaceutical research services; Biomedical research services; Biotechnology research, namely, in the field of genetic editing; Clinical research in the field of gene editing; Drug discovery services; Medical and scientific research in the field of cancer treatment; Medical and scientific research in the field of treatment of rare genetic diseases and disorders; Medical research; Medical research services, namely, for the treatment of cystic fibrosis and lung cancer; Providing laboratory research services in the field of gene expression, namely, cancer biology; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Research in the field of genetic editing; Research on the subject of pharmaceuticals, namely, pharmaceuticals to treat genetic disorders, cystic fibrosis and lung cancer; Scientific investigations for medical purposes; Scientific research in the field of oncology; Scientific study and research in the field of oncology; Technical consulting in the field of pharmaceutical studies; Technical research in the field of pharmaceutical studies; Medical and scientific research in the field of genetic engineering, namely, platform gene editing technology; Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Scientific research in the field of genetics and genetic engineering; Platform as a service (PAAS) featuring computer software platforms for gene editing

Filing History

WITHDRAWAL OF ATTORNEY GRANTED
Jun 3, 2026 WOAG
TEAS WITHDRAWAL OF ATTORNEY RECEIVED
Jun 3, 2026 WOAR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
May 2, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
May 2, 2023 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Mar 25, 2023 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Mar 24, 2023 CNPR
ASSIGNED TO EXAMINER
Mar 10, 2023 DOCK
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 17, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 17, 2023 CRFA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jan 17, 2023 CHAN
ASSIGNED TO LIE
Jan 17, 2023 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 10, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 17, 2022 GNRN
NON-FINAL ACTION E-MAILED
Jul 17, 2022 GNRT
SU - NON-FINAL ACTION - WRITTEN
Jul 17, 2022 CNRT
STATEMENT OF USE PROCESSING COMPLETE
May 16, 2022 SUPC
USE AMENDMENT FILED
May 10, 2022 IUAF
TEAS STATEMENT OF USE RECEIVED
May 10, 2022 EISU
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 16, 2021 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 16, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 16, 2021 REAP
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Dec 7, 2021 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 12, 2021 NPUB
PUBLISHED FOR OPPOSITION
Oct 12, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 22, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 9, 2021 CNSA
DIVISIONAL PROCESSING COMPLETE
Aug 11, 2021 DPCC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Aug 2, 2021 AITU
ASSIGNED TO LIE
Jul 7, 2021 ALIE
DIVISIONAL REQUEST RECEIVED
May 19, 2021 DRRR
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 19, 2021 TROA
TEAS REQUEST TO DIVIDE RECEIVED
May 19, 2021 ERTD
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 29, 2020 GNRN
NON-FINAL ACTION E-MAILED
Nov 29, 2020 GNRT
NON-FINAL ACTION WRITTEN
Nov 29, 2020 CNRT
ASSIGNED TO EXAMINER
Nov 28, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 4, 2020 NWOS
NEW APPLICATION ENTERED
Aug 8, 2020 NWAP